Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s Net Profit Rose 82.8% in First Quarter of 2023

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (上海复旦张江生物医药股份有限公司) (688505.SH) reported a net profit of 8.8 million yuan in the first quarter of 2023, up 82.8% year-on-year.

Meanwhile, the company posted 189.1 million yuan in revenue, up 34.3% year-on-year.

At the end of the reporting period, it had 2.9 billion yuan in total assets and 588.4 million yuan in total liabilities, with a liability-to-asset ratio of 20.6%.